Skin immunisation activates an innate lymphoid cell-monocyte axis regulating CD8
Adenoviruses, Human
/ genetics
Administration, Cutaneous
Animals
CD8-Positive T-Lymphocytes
/ immunology
Chemokine CXCL9
Disease Models, Animal
Female
Genitalia, Female
/ cytology
HEK293 Cells
Host-Pathogen Interactions
/ immunology
Humans
Immunity, Innate
Mice
Mice, Inbred C57BL
Monocytes
/ immunology
Mucous Membrane
/ cytology
Receptors, CXCR3
Skin
/ cytology
Treatment Outcome
Vaccination
/ methods
Vaccines, Synthetic
/ administration & dosage
Viral Vaccines
/ administration & dosage
Virus Diseases
/ immunology
gag Gene Products, Human Immunodeficiency Virus
/ genetics
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
17 05 2019
17 05 2019
Historique:
received:
15
09
2018
accepted:
08
04
2019
entrez:
19
5
2019
pubmed:
19
5
2019
medline:
7
6
2019
Statut:
epublish
Résumé
CD8
Identifiants
pubmed: 31101810
doi: 10.1038/s41467-019-09969-2
pii: 10.1038/s41467-019-09969-2
pmc: PMC6525176
doi:
Substances chimiques
CXCL9 protein, human
0
CXCR3 protein, human
0
Chemokine CXCL9
0
Receptors, CXCR3
0
Vaccines, Synthetic
0
Viral Vaccines
0
gag Gene Products, Human Immunodeficiency Virus
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2214Subventions
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/LO27933/2
Pays : International
Organisme : Medical Research Council
ID : MR/M003493/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0802068
Pays : United Kingdom
Organisme : EC | EC Seventh Framework Programm | FP7 People: Marie-Curie Actions (FP7-PEOPLE - Specific Programme "People" Implementing the Seventh Framework Programme of the European Community for Research, Technological Development and Demonstration Activities (2007 to 2013))
ID : 607690
Pays : International
Organisme : Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation)
ID : 38639
Pays : International
Organisme : British Heart Foundation (BHF)
ID : CH/11/2/28733
Pays : International
Organisme : Medical Research Council
ID : MR/N006445/1
Pays : United Kingdom
Références
J Immunol. 2011 Jan 15;186(2):745-53
pubmed: 21148794
J Immunol. 2010 Dec 15;185(12):7480-6
pubmed: 21076062
Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22213-8
pubmed: 21135247
Mol Ther. 2017 May 3;25(5):1222-1233
pubmed: 28342639
Immunity. 2014 Dec 18;41(6):886-97
pubmed: 25526304
PLoS One. 2010 Oct 20;5(10):e15373
pubmed: 20975955
Cell Host Microbe. 2015 Jul 8;18(1):27-37
pubmed: 26159718
J Immunol. 2010 May 15;184(10):5903-13
pubmed: 20404274
Cell. 2017 Oct 5;171(2):398-413.e21
pubmed: 28942919
Nat Med. 2010 Feb;16(2):224-7
pubmed: 20081864
J Immunol. 2007 Feb 15;178(4):2370-9
pubmed: 17277143
Proc Natl Acad Sci U S A. 2012 May 1;109(18):7037-42
pubmed: 22509047
Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):13236-13241
pubmed: 29180433
Cell. 2014 Apr 10;157(2):340-356
pubmed: 24725403
Nat Immunol. 2013 Mar;14(3):221-9
pubmed: 23334791
Cell Host Microbe. 2010 Sep 16;8(3):260-70
pubmed: 20833377
PLoS Pathog. 2012;8(3):e1002557
pubmed: 22396645
Nature. 2012 Nov 15;491(7424):463-7
pubmed: 23075848
Mol Ther. 2006 Jul;14(1):118-28
pubmed: 16580883
Nat Immunol. 2016 Feb;17(2):204-13
pubmed: 26726811
Immunity. 2009 Jul 17;31(1):110-21
pubmed: 19576795
J Exp Med. 1998 Jan 5;187(1):1-14
pubmed: 9419206
J Immunol. 2010 Apr 15;184(8):4431-9
pubmed: 20212099
N Engl J Med. 2000 Oct 5;343(14):1020-34
pubmed: 11018170
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3041-6
pubmed: 23386724
Nature. 2011 May 26;473(7348):523-7
pubmed: 21562493
J Immunol. 2005 Nov 1;175(9):5895-903
pubmed: 16237082
Immunity. 2002 Jan;16(1):1-4
pubmed: 11825560
Mucosal Immunol. 2013 May;6(3):498-510
pubmed: 22990622
J Immunol. 2008 Sep 15;181(6):4188-98
pubmed: 18768876
J Immunol. 1999 Nov 15;163(10):5535-43
pubmed: 10553081
Nat Med. 2018 Feb;24(2):130-143
pubmed: 29334373
Immunity. 2012 Jun 29;36(6):1047-59
pubmed: 22749354
Nat Med. 2005 Apr;11(4 Suppl):S45-53
pubmed: 15812489
Cell. 2017 Nov 2;171(4):795-808.e12
pubmed: 29056343
Mol Ther. 2002 Feb;5(2):115-24
pubmed: 11829518
J Virol. 2002 Nov;76(22):11659-76
pubmed: 12388726
Immunity. 2004 Oct;21(4):527-38
pubmed: 15485630
PLoS Pathog. 2017 Jun 14;13(6):e1006435
pubmed: 28614386
J Exp Med. 2010 Mar 15;207(3):553-64
pubmed: 20156972
J Exp Med. 2002 Jan 7;195(1):135-41
pubmed: 11781372
J Immunol. 2008 Sep 15;181(6):3745-9
pubmed: 18768825
J Immunol. 2001 Feb 1;166(3):1796-802
pubmed: 11160226
Cell. 1992 Mar 6;68(5):869-77
pubmed: 1547488
Immunity. 2013 Sep 19;39(3):599-610
pubmed: 24012416
Arch Virol. 2003 May;148(5):827-39
pubmed: 12721793
Immunol Cell Biol. 2011 Feb;89(2):207-15
pubmed: 21221121
Nat Immunol. 2011 Jun;12(6):485-91
pubmed: 21739671
Infect Immun. 1991 Sep;59(9):2892-900
pubmed: 1679040
J Exp Med. 1996 Nov 1;184(5):1879-90
pubmed: 8920875
Immunity. 2015 Jun 16;42(6):1130-42
pubmed: 26070484
J Immunol. 2010 May 1;184(9):4842-51
pubmed: 20351191
J Clin Invest. 2015 Mar 2;125(3):1129-46
pubmed: 25642773
Nature. 2009 Nov 26;462(7272):510-3
pubmed: 19898495
Immunity. 2006 Sep;25(3):511-20
pubmed: 16973385
Nat Rev Immunol. 2012 Jul 25;12(8):592-605
pubmed: 22828912
Immunity. 2008 Nov 14;29(5):819-33
pubmed: 19006696
J Control Release. 2017 Dec 28;268:166-175
pubmed: 29056444
Vaccine. 2014 Feb 3;32(6):717-24
pubmed: 24325826
Cell Host Microbe. 2014 Mar 12;15(3):351-62
pubmed: 24629341
Hum Gene Ther. 2006 Jul;17(7):705-16
pubmed: 16839270
Immunity. 2014 Oct 16;41(4):633-45
pubmed: 25308332
J Immunol. 2005 Aug 1;175(3):1751-7
pubmed: 16034116
Immunity. 2013 Apr 18;38(4):769-81
pubmed: 23453631
J Immunol. 2017 Sep 1;199(5):1923-1932
pubmed: 28760882
Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):E1754-62
pubmed: 25831525
J Immunol. 2017 Mar 15;198(6):2233-2237
pubmed: 28159905